OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LncRNA LINC00963 promotes colorectal cancer cell proliferation and metastasis by regulating miR‑1281 and TRIM65
Haidong Lv, Dixia Zhou, Guoqing Liu
Molecular Medicine Reports (2021) Vol. 24, Iss. 5
Open Access | Times Cited: 12
Haidong Lv, Dixia Zhou, Guoqing Liu
Molecular Medicine Reports (2021) Vol. 24, Iss. 5
Open Access | Times Cited: 12
Showing 12 citing articles:
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 53
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 53
Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer
Zahra Pezeshkian, Stefania Nobili, Noshad Peyravian, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6226-6226
Open Access | Times Cited: 50
Zahra Pezeshkian, Stefania Nobili, Noshad Peyravian, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6226-6226
Open Access | Times Cited: 50
TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway
Meixiu Jiang, Dan Wang, Ning Su, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111494-111494
Closed Access | Times Cited: 7
Meixiu Jiang, Dan Wang, Ning Su, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111494-111494
Closed Access | Times Cited: 7
LINC00963: A potential cancer diagnostic and therapeutic target
Zijun Xie, Chenming Zhong, Jinze Shen, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113019-113019
Open Access | Times Cited: 26
Zijun Xie, Chenming Zhong, Jinze Shen, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113019-113019
Open Access | Times Cited: 26
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape
Junjie Gu, Jingyi Chen, Shuaixi Xiang, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 147-179
Open Access | Times Cited: 12
Junjie Gu, Jingyi Chen, Shuaixi Xiang, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 147-179
Open Access | Times Cited: 12
Identification and molecular mechanism study of a novel small molecule inhibitor targeting solute carrier family 7 member 11 for the treatment of hepatocellular carcinoma
Xiaomeng Wang, Yan Yang, Qiao Fu, et al.
New Journal of Chemistry (2025)
Closed Access
Xiaomeng Wang, Yan Yang, Qiao Fu, et al.
New Journal of Chemistry (2025)
Closed Access
Multidimension Analysis of the Prognostic Value, Immune Regulatory Function, and ceRNA Network of LY6E in Individuals with Colorectal Cancer
Ting Li, Weidong Liu, Wang Chun, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 9
Ting Li, Weidong Liu, Wang Chun, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 9
lncRNA TRPM2-AS Promotes Colorectal Cancer Progression by Regulating miR-22-3p and FSTL1
Yongsheng Gao, Bing Liu, Xin Liu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 7
Yongsheng Gao, Bing Liu, Xin Liu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 7
Depletion of Fibroblast Growth Factor 12 Restrains the Viability, Stemness, and Motility of Colorectal Cancer
Xueyuan Gao, Zuowei Liao, Rukui Su, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 5
Xueyuan Gao, Zuowei Liao, Rukui Su, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 5
Supplementary kumatakenin prevents esophagus cancer progression by blocking TRIM65-FASN axis-mediated metabolic reprogramming
Tingting Zhang, Zhengqiang Yang, Xu Li, et al.
Journal of Functional Foods (2024) Vol. 117, pp. 106223-106223
Open Access
Tingting Zhang, Zhengqiang Yang, Xu Li, et al.
Journal of Functional Foods (2024) Vol. 117, pp. 106223-106223
Open Access
Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer
Shristi Bhattarai, Bruna M. Sugita, Emanuelle Nunes-Souza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13679-13679
Open Access
Shristi Bhattarai, Bruna M. Sugita, Emanuelle Nunes-Souza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13679-13679
Open Access
A systematic review and meta-analysis of long noncoding RNA 00963 expression and prognosis and clinicopathological characteristic in human cancers
Jin He, Zhuo Wang, Yongfeng Wang, et al.
Pathology - Research and Practice (2022) Vol. 242, pp. 154291-154291
Closed Access | Times Cited: 2
Jin He, Zhuo Wang, Yongfeng Wang, et al.
Pathology - Research and Practice (2022) Vol. 242, pp. 154291-154291
Closed Access | Times Cited: 2
